HAX1 and breast cancer: Interestingly, the analysis of the correlation of expression with HAX1, performed for the TCGA database in four neoplasms (AML, DLBCL, breast cancer, cervical cancer), identified enrichment in the same biological processes as detected for HAX1 KO vs. WT in the HL-60 cell line, indicating that these results are not cell line or neoplasm-specific, and thus further corroborating these findings.